𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

✍ Scribed by Vicenç Soriano; Javier Garcia-Samaniego; Rosa Bravo; Angeles Castro; Pedro M. Odriozola; Juan González; Miguel Colmenero; Ester Carballo; Dolores Suárez; Josep M Llibre; Juan Carlos Alberdi; José Pedreira; Juan González-Lahoz

Book ID
108407396
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
535 KB
Volume
31
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with recombinant α-interferon
Treatment with recombinant α-interferon of chronic hepatitis C in anti-HIV-positive patients
✍ Eduardo Marriott; Sonia Navas; Jorge Del Romero; Soledad Garcia; Inmaculada Cast 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Abstract A pilot study of chronic hepatitis C treatment was conducted in 14 patients (13 had chronic active hepatitis and 1 had liver cirrhosis). All patients were asymptomatic for the human immunodeficiency virus (HIV) type 1 (mean CD4 count of 584 ± 283 cells/mm^3^). Patients received 9 MU rlF

Immune response in chronic hepatitis C–i
Immune response in chronic hepatitis C–infected patients undergoing interferon treatment
✍ Antonietta Cargnel; Guido Gubertini; Carlo Magnani; Simona Bosis; Fulvia Colombo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

The findings of Mason et al. 1 on diabetes mellitus and hepatitis C are similar to our own, reported at the 8th European Congress of Clinical Microbiology and Infectious Diseases. 2 In our study, diabetes was found in 34.7% and 2.7% of chronic hepatitis C and chronic hepatitis B patients, respective